Error: Could not add to watchlist. X
+ Watchlist

Avantogen Oncology Inc

AVTO:US
OTC US
USD
Volume
0
Previous Close
0.01
52Wk Range
0.00 - 0.06
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Previous Close
0.01
52Wk Range
0.00 - 0.06
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.09
Market Cap (USD)
-
Shares Outstanding (m)
74.282
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Avantogen Oncology, Inc. acquires and develops pharmaceutical compounds focused on the treatment of cancer. The Company has a portfolio of several compounds targeted against various cancers and cancer related diseases. Avantogen seeks to license the compounds at an early stage of development, and then develop and commercialize them by partnering with pharmaceutical companies.
Address
530 South Lake Avenue
Pasadena, CA 91101
United States
Phone
1-917-969-4681
Website
-